BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 15485095)

  • 21. Is obstetric antiphospholipid syndrome a primary nonthrombotic, proinflammatory, complement-mediated disorder related to antiphospholipid antibodies?
    Alijotas-Reig J; Vilardell-Tarres M
    Obstet Gynecol Surv; 2010 Jan; 65(1):39-45. PubMed ID: 20040128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Association between anti-phospholipid antibodies and thrombotic complications in systemic lupus erythematosus].
    Nojima J
    Rinsho Byori; 2003 Mar; 51(3):239-47. PubMed ID: 12707997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiphospholipid antibodies and thrombosis.
    Brighton TA; Chesterman CN
    Baillieres Clin Haematol; 1994 Sep; 7(3):541-57. PubMed ID: 7841600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I.
    Di Simone N; Meroni PL; de Papa N; Raschi E; Caliandro D; De Carolis CS; Khamashta MA; Atsumi T; Hughes GR; Balestrieri G; Tincani A; Casali P; Caruso A
    Arthritis Rheum; 2000 Jan; 43(1):140-50. PubMed ID: 10643710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiphospholipid antibodies: specificity and pathophysiology.
    de Groot PG; Oosting JD; Derksen RH
    Baillieres Clin Haematol; 1993 Sep; 6(3):691-709. PubMed ID: 8025348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary recurrent miscarriages: anti-beta2-glycoprotein I IgG antibodies induce an acquired activated protein C resistance that can be detected by the modified activated protein C resistance test.
    Mercier E; Quere I; Mares P; Gris JC
    Blood; 1998 Oct; 92(8):2993-4. PubMed ID: 9763596
    [No Abstract]   [Full Text] [Related]  

  • 28. [Significance of the determination of B2-glycoprotein-1 antibodies in recognizing the thrombogenicity in antiphospholipid syndrome].
    Serdiuk GV; Selivanov EV; Barkagan ZS
    Klin Lab Diagn; 2008 Mar; (3):38-9. PubMed ID: 18453060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prevalence of a non-phospholipid-binding form of beta2-glycoprotein I in human plasma--consequences for the development of anti-beta2-glycoprotein I antibodies.
    Horbach DA; van Oort E; Tempelman MJ; Derksen RH; de Groot PG
    Thromb Haemost; 1998 Nov; 80(5):791-7. PubMed ID: 9843173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiphospholipid antibodies in arterial thrombosis.
    Koike T
    Ann Med; 2000 Dec; 32 Suppl 1():27-31. PubMed ID: 11209978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism.
    Rand JH; Wu XX; Andree HA; Lockwood CJ; Guller S; Scher J; Harpel PC
    N Engl J Med; 1997 Jul; 337(3):154-60. PubMed ID: 9219701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiphospholipid antibodies: effects on trophoblast and endothelial cells.
    D'Ippolito S; Di Simone N; Di Nicuolo F; Castellani R; Caruso A
    Am J Reprod Immunol; 2007 Aug; 58(2):150-8. PubMed ID: 17631008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk assessment in patients with antiphospholipid antibodies.
    Bertero M; Kuzenko A
    Minerva Med; 2013 Dec; 104(6):639-48. PubMed ID: 24316917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent trends in the management of antiphospholipid syndrome (Hughes syndrome).
    Espinosa G; Cervera R
    Drugs Today (Barc); 2010 Jan; 46(1):39-47. PubMed ID: 20200695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seronegative antiphospholipid syndrome.
    Nayfe R; Uthman I; Aoun J; Saad Aldin E; Merashli M; Khamashta MA
    Rheumatology (Oxford); 2013 Aug; 52(8):1358-67. PubMed ID: 23502076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
    Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A
    Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoimmune thrombophilic syndromes.
    Greaves M
    Haematologica; 1999 Jun; 84 Suppl EHA-4():32-5. PubMed ID: 10907462
    [No Abstract]   [Full Text] [Related]  

  • 38. Are anti-beta-glycoprotein-I antibodies markers for recurrent pregnancy loss in lupus anticoagulant/anticardiolipin seronegative women?
    Alijotas-Reig J; Casellas-Caro M; Ferrer-Oliveras R; Llurba-Olive E; Hermosilla E; Vilardell-Tarres M; Cabero-Roura L
    Am J Reprod Immunol; 2008 Sep; 60(3):229-37. PubMed ID: 18782284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical significance of antiphospholipid antibodies].
    Atsumi T; Koike T
    Rinsho Byori; 1998 Apr; 46(4):297-302. PubMed ID: 9594618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of multiple annexin autoantibodies in a patient with recurrent miscarriages, fulminant stroke and seronegative antiphospholipid syndrome.
    Scholz P; Auler M; Brachvogel B; Benzing T; Mallman P; Streichert T; Klatt AR
    Biochem Med (Zagreb); 2016; 26(2):272-8. PubMed ID: 27346975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.